Table 3. TEAEs reported in cycles 1–4 (safety analysis set).
All TEAEs except injection site reactions.
Abbreviations: N, number of patients in a treatment group or analysis set; n, number of patients with at least one episode; TEAE, treatment‐emergent adverse event.